Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective.

[1]  D. Harrison,et al.  Acute and Chronic Pharmacodynamic Interaction of Verapamil and Digoxin in Atrial Fibrillation , 1982, Circulation.

[2]  E. Kaplinsky,et al.  The Influence of Verapamil on Serum Digoxin Concentration , 1982, Circulation.

[3]  W. Vaughn,et al.  Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.

[4]  R. Robson,et al.  Nifedipine and beta-blockade as a cause of cardiac failure. , 1982, British medical journal.

[5]  S. Butman,et al.  Verapamil Versus Placebo in Relieving Stable Angina Pectoris , 1982, Circulation.

[6]  G. Sutton,et al.  Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine. , 1981, British heart journal.

[7]  R. Chahine,et al.  Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. , 1981, The American journal of medicine.

[8]  G. Belz,et al.  DIGOXIN PLASMA CONCENTRATIONS AND NIFEDIPINE , 1981, The Lancet.

[9]  C. Anastassiades.  Nifedipine and beta-blocker drugs. , 1980, British medical journal.

[10]  E. Leahey.  Digoxin-quinidine interaction: current status. , 1980, Annals of internal medicine.

[11]  G. Ellrodt,et al.  Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. , 1980, Circulation.

[12]  L. Brasseur,et al.  Impaired Early Left Ventricular Relaxation in Coronary Artery Disease: Effects of Intracoronary Nifedipine , 1980, Circulation.

[13]  S. Matsumoto,et al.  Hemodynamic effects of nifedipine in congestive heart failure. , 1980, The American journal of cardiology.

[14]  M. Olivari,et al.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. , 1979, The American journal of medicine.

[15]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[16]  H. Sacks,et al.  Verapamil in cardiac arrhythmias. , 1972, British medical journal.

[17]  W. Nayler,et al.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. , 1972, Cardiovascular research.

[18]  J. Apitz,et al.  [Death after intravenous application of isoptin]. , 1971, Medizinische Klinik.

[19]  W. Nayler,et al.  The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle. , 1969, Cardiovascular research.

[20]  W. Nayler,et al.  Some effects of iproveratril (Isoptin) on the cardiovascular system. , 1968, The Journal of pharmacology and experimental therapeutics.

[21]  J. R. Schmid,et al.  A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. , 1967, The Journal of pharmacology and experimental therapeutics.

[22]  A. Luisada,et al.  DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORIS , 1966, The American journal of the medical sciences.

[23]  R. Bing,et al.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. , 1966, The American journal of cardiology.

[24]  K. I. Melville,et al.  CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL. , 1965, Canadian journal of physiology and pharmacology.

[25]  H. Haas,et al.  [(N-methyl-N-homoveratryl)-gamma-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, a substance with coronary vasodilating properties]. , 1962, Arzneimittel-Forschung.